FdaApplication
NDA 022173
Identifiers
- fda_app_no: NDA022173
Properties
| Property | Value |
|---|---|
| applicant_name | CHEPLAPHARM REGISTRATION GMBH |
| application_type | NDA |
| approval_date | 2009-12-11 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZYPREXA RELPREVV | OLANZAPINE PAMOATE | EQ 405MG BASE/VIAL | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| ZYPREXA RELPREVV | OLANZAPINE PAMOATE | EQ 300MG BASE/VIAL | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| ZYPREXA RELPREVV | OLANZAPINE PAMOATE | EQ 210MG BASE/VIAL | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
3 products